Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial-Reference-Cited by-同舟云学术

Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial

Published:2018-04 Issue:4 Volume:175 Page:327-335
ISSN:0002-953X
Container-title:American Journal of Psychiatry
language:en
Short-container-title:AJP

Author:

Grunebaum Michael F.¹,Galfalvy Hanga C.¹,Choo Tse-Hwei¹,Keilp John G.¹,Moitra Vivek K.¹,Parris Michelle S.¹,Marver Julia E.¹,Burke Ainsley K.¹,Milak Matthew S.¹,Sublette M. Elizabeth¹,Oquendo Maria A.¹,Mann J. John¹

Affiliation:

1. From the Molecular Imaging and Neuropathology Division, Department of Psychiatry, and the Department of Anesthesiology, Columbia University Medical Center and New York State Psychiatric Institute, New York.

Publisher

American Psychiatric Association Publishing

Subject

Psychiatry and Mental health

Cited by 319 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Anesthetic Agents in Depression;Cottrell & Patel's Neuroanesthesia;2025

2. Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment‐resistant depression: A double‐blind, randomized, placebo‐controlled trial;Psychiatry and Clinical Neurosciences;2024-08-30

3. CETAMINA COMO INTERVENÇÃO TERAPÊUTICA NA DEPRESSÃO PSICÓTICA E DEPRESSÃO REFRATÁRIA A TRATAMENTO;RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218;2024-08-29

4. Intravenous patient-controlled analgesia with esketamine improves early depressive symptoms in patients with postherpetic neuralgia: a single-center retrospective cohort study;BMC Psychiatry;2024-08-27

5. Assessing suicide risk in chronic pain management: a narrative review across drug classes;Expert Opinion on Drug Safety;2024-08-19